Ipsen, Dicerna in cancer and endocrine deal

Ipsen Group (Euronext:IPN) and Dicerna Pharmaceuticals Inc. (Watertown, Mass.) partnered to develop conjugates of Dicerna's Dicer Substrate short interfering RNA (DsiRNA) molecules and Ipsen's peptide...